@CecileCrapart@karnika0696@D6Mad@HazelLRoberts Dr Ryan Bevan's The First Responders
A stunning image depicting microglia (red and cyan) responding to amyloid plaque (yellow), one of the hallmarks of Alzheimer’s.
6/7
It was an honour to present my work on PLCG2 and microglia at #ARUKConf2024 in Liverpool & receive the De Laszlo Foundation Prize for my work in dementia research as an Early Career Researcher. It was great catching up with other Alzheimer’s and dementia researchers.
Just 4 weeks left to secure your spot at #ARUKConf24 for an in-person experience!
Get the latest on dementia research from our expert-led sessions and talks, including vital topics like ‘Biology and immunity in dementia’
Register today: https://t.co/UgzDVwKBPw
Huge congrats to Prof Philip Taylor and @SarahCarpanini (UK DRI at Cardiff) who have been awarded funding from @AlzResearchUK to reveal the role genes play in driving the development of #Alzheimers👏👏
Find out more⬇️
https://t.co/bTrZBouImi
Go check out my recent manuscript that we uploaded to @biorxiv_neursci.
We found that the protective variant of PLCG2 expressed by microglia in the brain preserves synaptic integrity independently from amyloid burden in an amyloidosis model of AD. @UKDRI
https://t.co/MI71sN7cYG
We are delighted to announce the outstanding prize winners from our Microglia and Neuroinflammation conference! Kindly sponsored by Neuronal Signaling, @ASImmunology and @hello_bio, congratulations go to Ryan Bevan, Tim Birkle, Elina Svensson and Jonathan Pansieri!
We're delighted to announce the latest awardees of our Pilot Studies programme - designed to encourage UK DRI ECRs to consider new & innovative avenues of dementia research & take the next step towards independence👏 🎉 🙌 🧠
Check out all 8 projects👉https://t.co/FywQvT9f5X
Since its launch in 2017, the UK DRI has made important progress in overcoming dementia.
Now, we are thrilled to announce major funding that will set us on track for success in our next phase👉https://t.co/vgDegqKqO4
1/2
💡 Applications are open for an exciting PhD project at the UK DRI at Cardiff! Join Dr Dayne Beccano-Kelly's lab (@DayneBeccano) and investigate synaptic function and neurotransmitter release in Parkinson's disease👉 https://t.co/MG11NOIq5x
Excited to share our latest paper "Terminal complement pathway activation drives synaptic loss in AD models"
https://t.co/y0nyUnPe1X
@MTorvell @daskoulidou@DrRyanJBevan@Complement_BG@UKDRI
Publication: in 2020 we found that retinal ganglion cells degenerate in Alzheimer’s disease models
Paper- https://t.co/BypbbamXRW https://t.co/oI3KWGta3d
Publication: in 2020 we investigated the extent of grey matter pathology in multiple sclerosis whole coronal macrosections
Paper: https://t.co/5gzK42uuP0 https://t.co/VE81U7ehvJ
Publication: in 2018 we identified the presence of meningeal inflammation and cortical demyelination in the brains of acute multiple sclerosis.
Paper: https://t.co/Dj2uzvmguq https://t.co/frL1xSQFft
Publication: in 2017 we used tissue microarray methodology to identify complement deposition in the brain of progressive multiple sclerosis.
Paper: https://t.co/JEGDCwA50G https://t.co/RQqRVEo0Ny